Phase II study of RAD001 (everolimus) in patients with metastatic renal cell cancer

Trial Profile

Phase II study of RAD001 (everolimus) in patients with metastatic renal cell cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 22 Mar 2016

At a glance

  • Drugs Everolimus (Primary)
  • Indications Renal cancer
  • Focus Therapeutic Use
  • Acronyms RAD001
  • Most Recent Events

    • 10 Feb 2009 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
    • 24 Aug 2008 Planned end date changed to 1 Aug 2009.
    • 24 Aug 2008 Status changed from recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top